EdgeRx vs HealthRX
Two GLP-1 desks, one scoreboard. We put EdgeRx and HealthRX head-to-head on the published Brief Score — the same six factors, scored the same way.
HealthRX
The verdict
HealthRX takes this head-to-head.
HealthRX scores 86 to 84 on our six-factor Brief Score — A LegitScript-certified, physician-supervised desk (healthrx.com) whose real hook is breadth: injectable and a rare oral GLP tablet, on both molecules, with transparent no-insurance monthly pricing.
That doesn't make EdgeRx a bad call — it's best for men who want a straightforward, disclosed weekly-injectable price on either molecule and value knowing the pharmacy filling the script by name. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| EdgeRx | HealthRX | |
|---|---|---|
| Brief Score | 84/100 (B) | 86/100 (B) |
| Semaglutide | $229/mo injectable | $189/mo |
| Tirzepatide | $299/mo injectable | $349/mo |
| Coverage | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) | Not publicly listed |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Newnew to the tracker, no prior reading | Stableprice stable |
EdgeRx: First reading — flat weekly-injectable pricing on both molecules, named CMA and named 503A pharmacy.
HealthRX: Company-stated tiers held flat this cycle; the LegitScript badge and a rare oral GLP tablet are the draw, but some tiers are self-reported rather than checkout-verified.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.